KalVista is advancing science to empower everyday lives. Our mission begins with HAE.
KalVista is advancing science to empower everyday lives. Our mission begins with HAE.
At KalVista, we are working to empower people to enjoy everyday life beyond the challenges of their disease. With our scientific advances in orally-delivered small molecule medicines, we aim to change the treatment landscape to address the unmet needs of people living with hereditary angioedema (HAE).
We are dedicated to pushing beyond the limitations of current therapies to bring an oral therapy to patients that offers new possibilities to better manage HAE. Our goal with sebetralstat is to make a meaningful difference for people living with HAE.
Our team of talented professionals and experienced scientists are united in their determination to innovate with new drugs and elevate the standard of care for patients with a range of diseases, beginning with HAE.
